Fallopian Tube Serous Neoplasm
specificA benign, borderline, or malignant epithelial neoplasm that arises from the fallopian tube and is characterized by the presence of neoplastic serous epithelial cells.
20
Centers
8
Active Trials
—
Cancer Funding
Top Centers for Fallopian Tube Serous Neoplasm(20)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 66.0 |
| 2 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 66.0 |
| 3 | NCI Comprehensive Active Research Program | 66.0 |
| 4 | NCI Clinical Active Research Program | 66.0 |
| 5 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 66.0 |
| 6 | Boston University Cancer CenterBoston, MA Active Research Program | 66.0 |
| 7 | Active Research Program | 66.0 |
| 8 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 66.0 |
| 9 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 43.5 |
| 10 | NCI Comprehensive | 43.5 |
| 11 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 43.5 |
| 12 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 43.5 |
| 13 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 43.5 |
| 14 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 43.5 |
| 15 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 43.5 |
| 16 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive | 43.5 |
| 17 | University of Illinois Cancer CenterChicago, IL | 43.5 |
| 18 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 43.5 |
| 19 | Cancer Center at IllinoisUrbana, IL | 43.5 |
| 20 | Georgia Cancer Center, Augusta UniversityAugusta, GA | 43.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →